Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $3.76 Million - $5.09 Million
-31,700 Closed
0 $0
Q1 2023

Aug 11, 2023

BUY
$135.66 - $197.02 $4.3 Million - $6.25 Million
31,700 New
31,700 $4.87 Million
Q4 2022

Aug 11, 2023

BUY
$118.38 - $210.04 $5.2 Million - $9.22 Million
43,900 New
43,900 $7.89 Million
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $5.14 Million - $7.75 Million
43,900 New
43,900 $6.27 Million
Q4 2021

Jan 25, 2022

SELL
$225.82 - $368.51 $3.59 Million - $5.86 Million
-15,900 Closed
0 $0
Q3 2021

Oct 26, 2021

BUY
$221.9 - $484.47 $3.53 Million - $7.7 Million
15,900 New
15,900 $6.12 Million
Q3 2020

Oct 29, 2020

SELL
$54.34 - $94.85 $3.27 Million - $5.71 Million
-60,200 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$29.67 - $80.0 $1.79 Million - $4.82 Million
60,200 New
60,200 $3.87 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Railway Pension Investments LTD Portfolio

Follow Railway Pension Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Railway Pension Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Railway Pension Investments LTD with notifications on news.